Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Resection of Metastatic Pancreatic Neuroendocrine Tumors After Induction System Treatment: Real World Study

NCT04066322 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT04066322
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04066322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Resection of Metastatic Pancreatic Neuroendocrine Tumors After Induction System Treatment: Real World Study
Lead sponsor
Fudan University
Phase
Observational
Overall status
Unknown status
Start date
August 25, 2019
Completion date
July 25, 2025
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastases, neuroendocrine tumors, surgery